Marker X CO., LTD.
Update：2026/08/06
Industries
Main Industry
Biotechnology
Main Product/Service
Marker X provides advanced AI proteomics services that combine artificial intelligence with cutting-edge protein analysis technology to promote early disease detection and biomedical innovation. Their core offerings include AI Proteomics Early Cancer Scre
Founded Year
2020
Unified Business No.
82941917
Status
Active
Number of Employees
0
Total Paid-in
Capital
110,823,864 (NT$)
Location of Company
Taiwan
, Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
At Marker X, we are dedicated to providing the most accurate and effective multi-cancer early detection (MCED) method. Through the use of cutting-edge proteomic analysis, and artificial intelligence, we are able to detect cancer at its earliest stages, giving patients the best chance for pursuing their lives and creating value to the world.
